Logo image of EDT.CA

SPECTRAL MEDICAL INC (EDT.CA) Stock Price, Quote, News and Overview

TSX:EDT - Toronto Stock Exchange - CA8475771033 - Common Stock - Currency: CAD

0.83  -0.01 (-1.19%)

EDT.CA Quote, Performance and Key Statistics

SPECTRAL MEDICAL INC

TSX:EDT (5/22/2025, 7:00:00 PM)

0.83

-0.01 (-1.19%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High0.88
52 Week Low0.46
Market Cap236.65M
Shares285.12M
Float197.63M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)08-07 2025-08-07
IPO07-16 1992-07-16


EDT.CA short term performance overview.The bars show the price performance of EDT.CA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 10 20 30 40 50

EDT.CA long term performance overview.The bars show the price performance of EDT.CA in the last 1, 2 and 3 years. 1 year 2 years 3 years 50 100 150

The current stock price of EDT.CA is 0.83 CAD. In the past month the price increased by 3.75%. In the past year, price increased by 71.13%.

SPECTRAL MEDICAL INC / EDT Daily stock chart

EDT.CA Competitors/Peers

The largest stocks on the Canadian markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
FRX.CA FENNEC PHARMACEUTICALS INC N/A 307.74M
EPRX.CA EUPRAXIA PHARMACEUTICALS INC N/A 184.99M
TH.CA THERATECHNOLOGIES INC N/A 165.53M
MDNA.CA MEDICENNA THERAPEUTICS CORP N/A 86.04M
COV.CA COVALON TECHNOLOGIES LTD 15.94 74.31M
MSCL.CA SATELLOS BIOSCIENCE INC N/A 69.24M
BLU.CA BLUENERGIES LTD N/A 57.06M
SVA.CA SERNOVA BIOTHERAPEUTICS INC N/A 55.07M
HBP.CA HELIX BIOPHARMA CORP N/A 50.90M
MBX.CA MICROBIX BIOSYSTEMS INC 34 47.95M
ONC.CA ONCOLYTICS BIOTECH INC N/A 44.41M
BCT.CA BRIACELL THERAPEUTICS CORP N/A 32.00M

About EDT.CA

Company Profile

EDT logo image Spectral Medical, Inc. engages in the development and commercialization of therapeutic treatment for septic shock. The company is headquartered in Toronto, Ontario and currently employs 29 full-time employees. The firm develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. The company has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. The company is continuing its legacy business of manufacturing and selling certain proprietary reagents. The company develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

Company Info

SPECTRAL MEDICAL INC

135 The West Mall, Unit 2

TORONTO ONTARIO M9C 1C2 CA

CEO: Chris Seto

Employees: 29

EDT Company Website

EDT Investor Relations

Phone: 14166263233

SPECTRAL MEDICAL INC / EDT.CA FAQ

What is the stock price of SPECTRAL MEDICAL INC today?

The current stock price of EDT.CA is 0.83 CAD. The price decreased by -1.19% in the last trading session.


What is the ticker symbol for SPECTRAL MEDICAL INC stock?

The exchange symbol of SPECTRAL MEDICAL INC is EDT and it is listed on the Toronto Stock Exchange exchange.


On which exchange is EDT.CA stock listed?

EDT.CA stock is listed on the Toronto Stock Exchange exchange.


What is the price forecast or stock price prediction for SPECTRAL MEDICAL INC stock?

5 analysts have analysed EDT.CA and the average price target is 2.35 CAD. This implies a price increase of 182.65% is expected in the next year compared to the current price of 0.83. Check the SPECTRAL MEDICAL INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is SPECTRAL MEDICAL INC worth?

SPECTRAL MEDICAL INC (EDT.CA) has a market capitalization of 236.65M CAD. This makes EDT.CA a Micro Cap stock.


How many employees does SPECTRAL MEDICAL INC have?

SPECTRAL MEDICAL INC (EDT.CA) currently has 29 employees.


What are the support and resistance levels for SPECTRAL MEDICAL INC (EDT.CA) stock?

SPECTRAL MEDICAL INC (EDT.CA) has a support level at 0.78 and a resistance level at 0.84. Check the full technical report for a detailed analysis of EDT.CA support and resistance levels.


Is SPECTRAL MEDICAL INC (EDT.CA) expected to grow?

The Revenue of SPECTRAL MEDICAL INC (EDT.CA) is expected to grow by 23.53% in the next year. Check the estimates tab for more information on the EDT.CA EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy SPECTRAL MEDICAL INC (EDT.CA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does SPECTRAL MEDICAL INC (EDT.CA) stock pay dividends?

EDT.CA does not pay a dividend.


When does SPECTRAL MEDICAL INC (EDT.CA) report earnings?

SPECTRAL MEDICAL INC (EDT.CA) will report earnings on 2025-08-07.


What is the Price/Earnings (PE) ratio of SPECTRAL MEDICAL INC (EDT.CA)?

SPECTRAL MEDICAL INC (EDT.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.06).


EDT.CA Technical Analysis

ChartMill assigns a technical rating of 10 / 10 to EDT.CA. When comparing the yearly performance of all stocks, EDT.CA is one of the better performing stocks in the market, outperforming 91.76% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

EDT.CA Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to EDT.CA. EDT.CA may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

EDT.CA Financial Highlights

Over the last trailing twelve months EDT.CA reported a non-GAAP Earnings per Share(EPS) of -0.06. The EPS decreased by -42.7% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -289.53%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%-205.2%
Sales Q2Q%-18.61%
EPS 1Y (TTM)-42.7%
Revenue 1Y (TTM)-4.31%

EDT.CA Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 84% to EDT.CA. The Buy consensus is the average rating of analysts ratings from 5 analysts.

For the next year, analysts expect an EPS growth of -23.87% and a revenue growth 23.53% for EDT.CA


Ownership
Inst Owners0.04%
Ins Owners1.4%
Short Float %N/A
Short RatioN/A
Analysts
Analysts84
Price Target2.35 (183.13%)
EPS Next Y-23.87%
Revenue Next Year23.53%